# Alaunos Therapeutics, Inc.: Form 8-K, filed Sep 17, 2026

- Company: [Alaunos Therapeutics, Inc.](/companies/tcrt.md) (CIK 1107421)
- Form: 8-K
- Filed: 2026-09-17
- Accepted by EDGAR: Sep 16, 2026, 21:03 ET
- Period: 2026-09-16
- Accession: 0001193125-26-393462
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1107421/000119312526393462/tcrt-20260916.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1107421/000119312526393462/

## Items reported

- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1107421/000119312526393462/tcrt-20260916.htm

Filed Sep 17, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-393462. Last ingested by Listed: Nov 15, 2026, 00:22 ET. No prices; not investment advice.
